Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (75)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Inflammation uses soluble mediators
- Diverse stimuli trigger TNF and IL-1
- TNF augments neutrophil responsiveness
- Inflammation can increase circulating leukocytes
- Chemokines specialize in cellular navigation
- CCL3 is a further CC-family example
- Certain chemokine receptors are HIV coreceptors
- Primary reference
Slide index & full transcript (75 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Cytokines and Chemokines
Inflammatory signaling, leukocyte recruitment, and systemic responses
Cytokine signals
Leukocyte movement
Systemic responses
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning outcomes
Identify principal cytokine sources and their major inflammatory actions.
Explain TNF- and IL-1–driven endothelial and leukocyte activation.
Relate cytokine effects to fever, acute-phase responses, and cachexia.
Distinguish chemokine families, receptors, and tissue-specific functions.
Slide 3 · Inflammation uses soluble mediators
Injury or microbial stimulus
Local danger signals initiate inflammation
Sentinel-cell response
Macrophages and dendritic cells release mediators
Target-cell activation
Endothelium and leukocytes change behavior
Tissue response
Recruitment, defense, and systemic manifestations
Cytokines coordinate cells; Chemokines help direct leukocyte movement.
Slide 4 · Cytokines: Functional definition
Protein mediators made by many cell types.
Regulate and mediate immune and inflammatory reactions.
Important producers include activated lymphocytes, macrophages, and dendritic cells.
Epithelial, endothelial, and connective tissue cells can also produce them.
Slide 5 · Immune cells and tissue cells both signal
Immune-cell sources
Activated T lymphocytes
Macrophages and dendritic cells
Mast cells; Selected cytokines
Resident-tissue sources
Endothelial and epithelial cells
Connective tissue cells
Site of injury becomes an active signaling compartment
Signaling is not restricted to circulating leukocytes.
Slide 6 · Scope: Inflammatory cytokines versus growth factors
Here, the principal focus is cytokines participating in inflammation.
Growth factors acting on epithelial and mesenchymal cells are conventionally considered separately.
Individual mediators can act on multiple cell types and have overlapping effects.
These slides emphasize tissue responses rather than a full catalogue of immune signaling.
Slide 7 · Major cytokines in acute inflammation
Mediator
Main source(s)
Characteristic role
TNF
Macrophages, DCs, mast cells, T cells
Endothelial activation; systemic effects
IL-1
Macrophages, DCs, epithelia
TNF-like actions; prominent fever role
IL-6
Macrophages, other cells
Acute-phase and systemic responses
IL-17
T lymphocytes
Neutrophil and monocyte recruitment
DC = dendritic cell. These mediators have distinct emphases but overlapping actions.
Slide 8 · Cytokines highlighted in chronic inflammation
Mediator
Principal source(s)
Key action
IL-12
Dendritic cells, macrophages
Increases interferon-γ production
IFN-γ
T and NK lymphocytes
Activates macrophage microbicidal responses
IL-17
T lymphocytes
Promotes neutrophil / monocyte recruitment
Acute/chronic categories overlap; The classification is functional, not absolute.
Slide 9 · Inflammatory signals form an interacting network
Activated innate cells
TNF
Endothelial activation
IL-1
Local and systemic effects
IL-6
Acute-phase response
These mediators have distinct emphases but substantial functional overlap.
Slide 10 · Acute and chronic cytokines overlap
Cytokines listed under acute inflammation can also act in chronic disease.
Chronic inflammation includes persistent leukocyte activation and additional lymphocyte-derived signals.
IL-12, IFN-γ, and IL-17 are prominent mediators in chronic inflammation.
Avoid treating acute and chronic cytokine lists as mutually exclusive.
Slide 11 · TNF is a central inflammatory amplifier
Tumor necrosis factor
Endothelium
Adhesion molecules and cytokines
Leukocytes
Enhanced responses to stimulation
Organ systems
Fever and metabolic consequences
The same mediator can have local protective and systemic pathological effects.
Slide 12 · Principal cellular sources of TNF
Activated macrophages and dendritic cells are major sources.
T lymphocytes and mast cells can also produce TNF.
The cellular source varies with the initiating stimulus and tissue microenvironment.
TNF can act on endothelial cells as well as recruited inflammatory cells.
Slide 13 · Diverse stimuli trigger TNF and IL-1
Biological stimuli
Microbial products
Dead or injured cells
Immune complexes
Other inflammatory stimuli
Foreign bodies
Physical injury
Other local triggers of inflammation
Cytokine release links danger recognition with an organized inflammatory response.
Slide 14 · Microbial sensing induces TNF
Microbial products
Recognized by TLRs and other sensors
Intracellular signals
Induce inflammatory gene expression
TNF production
Produced by stimulated sentinel cells
Tissue effects
Endothelial activation and leukocyte recruitment
TLR = Toll-like receptor; This is a simplified causal sequence.
Slide 15 · IL-1 shares stimuli but has an extra control step
Macrophages and dendritic cells are major sources of IL-1.
Some epithelial cells also produce IL-1.
Signals that induce TNF also stimulate IL-1 synthesis.
Generation of biologically active IL-1 depends on inflammasome activity.
Slide 16 · IL-1 requires synthesis and maturation
Inflammatory stimulus
Microbial sensing / cell damage signals
IL-1 synthesis
Production of the cytokine precursor
Inflammasome-dependent activation
Processing to biologically active IL-1
Effector response
Leukocyte recruitment and systemic effects
IL-1 protein synthesis and inflammasome-dependent activation are distinct steps.
Slide 17 · TNF and IL-1: Overlap and emphasis
Feature
TNF
IL-1
Main source
Macrophages / DCs; T cells and mast cells
Macrophages / DCs; some epithelia
Endothelial effect
Activation, adhesion molecules
Similar endothelial activation
Distinct emphasis
Cachexia / metabolic effects
Stronger role in fever
Upstream control
Microbial sensor signals
Inflammasome-dependent maturation
Overlap is substantial; “distinct emphasis” is not exclusivity.
Slide 18 · TNF and IL-1 initiate endothelial activation
TNF / IL-1
Signals released near inflammatory focus
Endothelial cells
Increase adhesion molecule expression
Leukocytes
Attach more effectively to vessel wall
Inflamed tissue
Increased extravasation into injured site
Endothelial activation is a prerequisite for efficient leukocyte recruitment.
Slide 19 · Endothelial activation changes the vessel wall
Up-regulates E-selectin and P-selectin.
Increases endothelial ligands for leukocyte integrins.
Stimulates additional inflammatory mediators and growth factors.
Increases the procoagulant activity of the endothelium.
Slide 20 · Selectins and integrin ligands are complementary
Selectins
E-selectin and P-selectin increase after activation.
Support early interactions between leukocytes and vessel wall.
Integrin ligands
Endothelial ligands support more stable leukocyte attachment.
Effective binding is enhanced by chemokine signaling to leukocytes.
Vessel-wall induction and leukocyte integrin activation cooperate.
Slide 21 · Leukocyte entry requires sequential signals
Activated endothelium
Adhesion molecules are displayed
Chemokines
Increase leukocyte integrin affinity
Firm leukocyte attachment
Stable interaction with endothelium
Migration
Leukocytes cross vessels and follow tissue signals
The steps represent distinct, coordinated components of recruitment.
Slide 22 · Activated endothelium becomes a signaling hub
TNF / IL-1 signal
Chemokines
Recruitment guidance
Cytokines
Amplify inflammatory communication
Eicosanoids
Additional inflammatory responses
The activated vascular wall is a source of mediators, not merely a passive barrier.
Slide 23 · Endothelial procoagulant changes
TNF and IL-1 can increase endothelial procoagulant activity.
This links inflammation to shifts in vascular hemostatic behavior.
When systemic responses become excessive, thrombosis may contribute to pathology.
Coagulation effects are one component of a wider cytokine response.
Slide 24 · TNF augments neutrophil responsiveness
TNF enhances neutrophil responses to other inflammatory signals.
Bacterial endotoxin is an example of a cooperating stimulus.
Augmented activation supports antimicrobial host defense.
In excessive inflammation, the same responses can contribute to tissue injury.
Slide 25 · TNF enhances macrophage microbicidal activity
TNF exposure
Macrophage activation
Induced nitric oxide
Part of increased microbicidal capacity
Microbial killing
More effective response to intracellular pathogens
Induction of nitric oxide (NO) contributes to macrophage microbicidal activity.
Slide 26 · IL-1 activates fibroblasts
IL-1 can stimulate fibroblasts to produce collagen.
The effect links an inflammatory mediator to mesenchymal cell responses.
This provides a mechanistic connection between persistent inflammation and matrix deposition.
The lecture scope is cytokine signaling, not a complete account of scar formation.
Slide 27 · IL-1 acts on mesenchymal and immune cells
Mesenchymal responses
Fibroblast collagen synthesis
Proliferation of synovial and other mesenchymal cells
Immune-cell responses
Stimulation of Th17 responses
Subsequent enhancement of inflammatory recruitment
One cytokine can influence both tissue remodeling and leukocyte responses.
Slide 28 · IL-1 can amplify Th17-associated inflammation
IL-1 signal
Favors Th17 responses
T-cell IL-17
Inflammatory cytokine release
Recruitment
Neutrophils and monocytes enter tissues
Local inflammation
Amplified cellular infiltrate
This is an explanatory cytokine sequence, not a complete model of T-cell differentiation.
Slide 29 · Local actions of TNF and IL-1
Target
Effect
Inflammatory consequence
Endothelium
Adhesion molecules and ligands
Leukocyte entry
Neutrophils / macrophages
Enhanced activation
Microbicidal defense
Fibroblasts
Collagen synthesis (IL-1)
Matrix production
Synovial cells
Proliferation (IL-1)
Mesenchymal expansion
Different target cells translate the same extracellular signal into distinct outcomes.
Slide 30 · Cytokines have local and systemic effects
TNF · IL-1 · IL-6
Local
Adhesion, leukocyte activation
Systemic protective
Fever, leukocytosis, acute-phase proteins
Systemic harmful
Metabolic and circulatory pathology
Magnitude, duration, and distribution influence whether the response protects or injures.
Slide 31 · Fever is a cytokine-driven systemic response
IL-1 and TNF participate in the febrile response.
IL-1 has a particularly prominent role in fever.
Cytokine-associated prostaglandin E₂ contributes to fever.
Fever is one of several coordinated systemic responses to infection or injury.
Slide 32 · Cytokines stimulate the acute-phase response
Infection or tissue injury
Macrophage / stromal cytokine release
IL-6 prominence
Signal to hepatic acute-phase response
Liver
Synthesis of acute-phase proteins
Circulation
CRP, fibrinogen, serum amyloid A increase
IL-6 is a major driver of hepatic acute-phase protein synthesis.
Slide 33 · Acute-phase proteins are downstream readouts
C-reactive protein (CRP) is an acute-phase protein.
Fibrinogen and serum amyloid A are additional examples.
Their synthesis reflects cytokine-driven hepatic responses.
They are systemic correlates of inflammation, not the initiating cytokines.
Slide 34 · Inflammation can increase circulating leukocytes
Inflammatory cytokines
Signal beyond the local tissue
Bone marrow response
Increased leukocyte output
Leukocytosis
Greater numbers of circulating inflammatory cells
Leukocytosis increases the circulating pool of host-defense leukocytes.
Slide 35 · Systemic responses: Protective and pathological
Protective responses
Fever
Leukocytosis
Increased acute-phase proteins
Potentially pathological responses
Circulatory dysfunction
Abnormal coagulation / thrombosis
Metabolic derangement and wasting
Physiological defense becomes harmful when responses are excessive or sustained.
Slide 36 · TNF participates in systemic metabolic regulation
TNF promotes mobilization of lipids and proteins.
TNF suppresses appetite.
Sustained production promotes negative nutritional and energy balance.
These actions can contribute to cachexia in chronic disease.
Slide 37 · Persistent TNF can contribute to cachexia
Persistent inflammation
Sustained TNF production
Metabolic effects
Lipid/protein mobilization
Appetite suppression
Reduced nutritional intake
Cachexia
Pathological weight loss and anorexia
Examples include some chronic infections and neoplastic diseases.
Slide 38 · Cachexia is not merely a local inflammatory sign
Cachexia includes anorexia and pathological weight loss.
It is associated with persistent inflammatory cytokine activity.
TNF is one important contributor, not a complete single-factor explanation.
Understanding systemic cytokine action explains why localized disease can cause generalized wasting.
Slide 39 · Systemic cytokine effects span multiple organs
Circulating mediators
Brain
Fever; Appetite modulation
Liver and marrow
Acute phase; Leukocytosis
Vessels and tissues
Coagulation and metabolic responses
Circulating inflammatory cytokines affect organs distant from the original lesion.
Slide 40 · TNF blockade illustrates clinical relevance
TNF antagonists are effective treatments for several chronic inflammatory diseases.
Examples include rheumatoid arthritis and psoriasis.
Certain forms of inflammatory bowel disease are additional examples.
Treatment benefit demonstrates the importance of TNF in disease pathogenesis.
Slide 41 · TNF blockade can impair intracellular defense
TNF antagonist
Reduced TNF signaling
Macrophage response
Reduced ability to kill intracellular microbes
Clinical consequence
Greater susceptibility to mycobacterial infection
This risk follows directly from the host-defense function of TNF.
Slide 42 · TNF and IL-1 inhibition are not interchangeable
TNF blockade
Notable efficacy in several chronic inflammatory diseases
Important intracellular infection risk
IL-1 blockade
Some overlapping biological targets
Not uniformly as effective for the diseases discussed
Reasons for the difference in effectiveness remain incompletely understood.
Slide 43 · Sepsis is not a single-cytokine disease
Inflammatory systemic responses can involve several cytokines simultaneously.
Blocking either TNF or IL-1 alone has not improved sepsis outcomes in the studies discussed.
Redundancy and mediator interactions may limit single-target interventions.
Therapeutic inference must not be confused with a complete contemporary treatment guideline.
Slide 44 · Chemokines specialize in cellular navigation
Small proteins with a principal role as leukocyte chemoattractants.
Recruit specific leukocyte populations in inflammation.
Also organize cell distribution within normal tissues.
They are typically small proteins of approximately 8–10 kDa.
Slide 45 · Chemokines have two biological contexts
Inflammatory chemokines
Induced by microbes and inflammatory signals
Promote attachment and migration to sites of injury
Homeostatic chemokines
Produced constitutively in tissues
Maintain localization of cells within tissue compartments
Chemotaxis is essential in both defense and normal tissue organization.
Slide 46 · Four chemokine families: Cysteine arrangement
Family
Conserved N-terminal cysteines
Example
CXC
C–X–C: one residue between
CXCL8 (IL-8)
CC
C–C: adjacent pair
CCL2 / CCL11 / CCL3
C
Two of four conserved Cys absent
XCL1 (lymphotactin)
CX3C
C–X₃–C: three intervening residues
CX3CL1 (fractalkine)
Classification refers to spacing of conserved cysteine residues.
Slide 47 · A subset of CXC chemokines recruits neutrophils
Inflammatory stimulus
Microbes or TNF / IL-1 signals
CXCL8 release
Activated macrophages and endothelial cells
Neutrophils
Activation and directed migration to tissue
A subset of CXC chemokines is especially active on neutrophils.
Slide 48 · CXCL8 is the former interleukin-8
IL-8 is now designated CXCL8.
Made by activated macrophages, endothelial cells, and additional cell types.
Promotes neutrophil activation and chemotaxis.
Has comparatively limited effects on monocytes and eosinophils.
Slide 49 · CXCL8 production is itself cytokine regulated
Microbial products
Direct inflammatory induction
TNF
Induces local chemokine production
IL-1
Also induces chemokine production
CXCL8 secretion
Neutrophil activation and chemotaxis
TNF and IL-1 can indirectly recruit neutrophils by inducing chemokines.
Slide 50 · CC chemokines target broader leukocyte sets
Conserved first two cysteines are adjacent.
Common targets: Monocytes, eosinophils, basophils, and lymphocytes.
In general, CC chemokines are less potent than some CXC members for neutrophils.
Functional overlap exists among the many CC family members.
Slide 51 · Illustrative CC chemokines
Chemokine
Alternative name
Source-supported association
CCL2
MCP-1
Monocyte chemoattractant
CCL11
Eotaxin
Relatively selective eosinophil recruitment
CCL3
MIP-1α
CC-family leukocyte chemoattraction
Examples are not an exhaustive receptor–ligand catalogue.
Slide 52 · CCL2 illustrates monocyte recruitment
CCL2 is also called monocyte chemoattractant protein-1 (MCP-1).
It belongs to the CC family of chemokines.
Its name reflects an important monocyte-directed chemoattractant role.
This differs from neutrophil-dominant CXCL8 signaling.
Slide 53 · CCL11 illustrates selective recruitment
CCL11 is commonly known as eotaxin.
It shows relatively selective eosinophil recruitment.
This shows that chemokines can confer leukocyte-subset preference.
Subset preference helps explain differing cellular compositions of infiltrates.
Slide 54 · CCL3 is a further CC-family example
CCL3 was historically called macrophage inflammatory protein-1α.
It is listed alongside CCL2 and CCL11 in the CC group.
Its inclusion underscores the diversity of leukocyte-active chemokines.
Family membership alone does not specify an exclusive single target cell.
Slide 55 · Rare structural families add specificity
C family
Example: XCL1 / lymphotactin
Missing first and third of four conserved cysteines
Relatively specific for lymphocytes
CX3C family
Example: CX3CL1 / fractalkine
Three residues separate first two conserved cysteines
Can support adhesion or chemoattraction
These structural families are not interchangeable with the CXC and CC families.
Slide 56 · Fractalkine has two biologically distinct forms
Cell-surface CX3CL1
Induced on endothelium by cytokines
Membrane-bound action
Strong monocyte and T-cell adhesion
Proteolytic cleavage
Soluble CX3CL1 is released
Soluble action
Chemoattraction of monocytes and T cells
One chemokine therefore supports both attachment and migration.
Slide 57 · Chemokine receptors are seven-pass GPCRs
Chemokine ligand
Binds a matching cell-surface receptor
7-transmembrane GPCR
G protein–coupled signal transduction
Leukocyte response
Increased integrin affinity and directed migration
GPCR = G protein–coupled receptor.
Slide 58 · Leukocytes express multiple chemokine receptors
Most leukocytes display more than one receptor type.
Consequently, a cell can respond to more than one chemokine signal.
Multiple ligand–receptor interactions permit overlapping recruitment programs.
This complexity helps explain difficulty of single-receptor inhibition.
Slide 59 · Endothelium presents chemokines to passing cells
Local cytokines / injury
Chemokines released
Endothelial proteoglycans
Chemokines retained at high surface concentration
Passing leukocyte
Encounters displayed chemokine
Integrin activation
Increased adhesion affinity
Extracellular matrix proteoglycans can also bind chemokines locally.
Slide 60 · Chemokines activate leukocyte integrin binding
Leukocyte near endothelium
Integrins present on cell surface
Chemokine receptor signal
Integrin affinity rises
Endothelial integrin ligand
Stable adhesive interaction
Transmigration
Leukocyte reaches inflamed tissue
Chemokines change leukocyte adhesive behavior rather than merely increasing cell movement.
Slide 61 · Tissue gradients direct leukocyte chemotaxis
Chemokine at inflamed focus
Local production in response to injury
Matrix-associated distribution
Spatially localized chemokine cue
Recruited leukocyte
Directional movement toward the focus
Directed tissue chemotaxis is a principal inflammatory chemokine function.
Slide 62 · Inflammatory versus homeostatic chemokines
Property
Inflammatory
Homeostatic
Production
Induced by damage / microbes
Constitutive
Principal task
Recruit leukocytes to tissue lesion
Maintain normal tissue organization
Important outcome
Inflammatory infiltrate
Cell positioning in lymphoid tissues
The distinction refers to typical biological roles, not separate protein chemistry.
Slide 63 · Homeostatic chemokines organize lymphoid tissue
Constitutively produced chemokines influence cell localization.
They help segregate T and B lymphocytes into discrete regions.
The spleen and lymph nodes show this organized lymphocyte distribution.
Normal architecture therefore depends in part on chemokine-directed positioning.
Slide 64 · Two contexts, one principle: Directed movement
Chemokine signal
Infection
Recruit effector leukocytes
Vessel wall
Increase integrin affinity
Lymphoid organ
Position lymphocyte subsets
Chemokines convey positional information in both inflammatory and physiological settings.
Slide 65 · Certain chemokine receptors are HIV coreceptors
CXCR4 and CCR5 can act as HIV coreceptors.
They participate in viral binding and entry into susceptible cells.
Their role in infection is distinct from their usual chemokine-signaling functions.
This illustrates a noninflammatory consequence of chemokine receptor expression.
Slide 66 · Chemokine-targeted therapy is challenging
Chemokine-mediated inflammation is well established experimentally.
Most leukocytes express multiple receptor types.
Many chemokine ligands display overlapping leukocyte actions.
Effective therapeutic chemokine antagonism has proven challenging.
Slide 67 · IL-6 is prominent in the acute-phase response
Macrophages and other cells
IL-6 is released
Circulating IL-6
Promotes systemic responses
Liver
Acute-phase protein production
IL-6 participates in local inflammation in addition to systemic reactions.
Slide 68 · IL-17 promotes myeloid leukocyte recruitment
Activated T lymphocytes
Major IL-17 source
IL-17 release
Promotes inflammatory recruitment
Inflamed tissue
Neutrophils and monocytes accumulate
IL-17 is relevant to acute as well as chronic inflammatory responses.
Slide 69 · Targeting IL-6 and IL-17 has clinical effects
IL-6 receptor inhibition
Example: Juvenile arthritis
Interferes with an important inflammatory cytokine pathway
IL-17 inhibition
Example: Psoriasis
Reduces signaling associated with myeloid recruitment
Examples illustrate mechanism-based therapy; They are not comprehensive prescribing guidance.
Slide 70 · One-page cytokine functional map
Mediator
Primary role emphasized
Cells / systems affected
TNF
Endothelial activation; cachexia
Vessels, leukocytes, metabolism
IL-1
Endothelial activation; fever
Vessels, fibroblasts, systemic
IL-6
Acute-phase response
Liver and systemic sites
IL-17
Recruitment of myeloid cells
Neutrophils and monocytes
Chemokines
Adhesion and chemotaxis
Specific recruited leukocytes
Functional emphasis from Chapter 3; Actions are not mutually exclusive.
Slide 71 · Application: Neutrophil-rich inflammation
Clinical reasoning prompt
An infected tissue becomes enriched in neutrophils. Nearby macrophages and endothelial cells are producing inflammatory mediators.
Which named chemokine best illustrates directed neutrophil recruitment?
Mechanistic explanation
CXCL8 (IL-8). It is induced by microbes and TNF / IL-1, and activates and attracts neutrophils.
Slide 72 · Application: Cytokine inhibition and infection
Clinical reasoning prompt
A patient receiving a TNF antagonist develops concern for an intracellular infection.
Which normal TNF function explains this susceptibility?
Mechanistic explanation
TNF helps macrophages kill intracellular microbes, in part through NO-associated microbicidal activation.
Slide 73 · Application: Endothelial activation
Clinical reasoning prompt
Inflamed endothelium displays more adhesion molecules while passing leukocytes respond to nearby chemokines.
Identify the complementary roles of TNF / IL-1 and chemokines.
Mechanistic explanation
TNF / IL-1 induce endothelial adhesion machinery; Chemokines increase leukocyte integrin affinity and direct tissue migration.
Slide 74 · Synthesis: Five mechanistic relationships
TNF and IL-1 convert danger signals into endothelial activation.
IL-1 activity requires inflammasome-dependent maturation.
IL-6 is a major mediator of the hepatic acute-phase response.
Chemokines connect leukocyte adhesion to directed tissue migration.
Excess or persistent cytokine activity can produce systemic pathology.
Slide 75 · Primary reference
Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026).
Chapter 3: Inflammation and Repair.
Section: Cytokines and Chemokines; Table 3.7 and Figure 3.10.
Figure- and table-derived concepts have been redrawn as original editable teaching schematics.